Cancer and hereditary haemorrhagic telangiectasia
Authors:
- 11 November 2016
- journal article
- letter
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 143 (2) , 369-370
Abstract
To examine associations between cancer incidence and hereditary haemorrhagic telangiectasia (HHT). Two studies with contrasting conclusions were compared. The first had used a registry-based, matched-pairs approach, while the second utilised HHT family-based, survey methodology. The first manuscript captured data on cancer incidence in a total of 316,581 matched cancer patients–non-cancer controls, which included 431 HHT cases. No association was found between HHT and pooled cases of lung, breast, prostate, and colorectal cancer (adjusted OR 0.978, 95% CI [0.795, 1.204]). The second, which was powered to examine these four cancers individually, captured data from 2161 HHT cases and 2817 related controls. Fewer HHT-affected individuals had cancer (398/2161, [18.4%]) compared to 668/2817 (23.7%) related controls (p = 0.0012). Of the four most common cancers, prostate and colorectal cancer rates were equivalent, but lung cancers were significantly less frequent in HHT (adjusted OR 0.48 [0.30, 0.70], p = 0.0012), and breast cancer was more frequent (adjusted OR 1.52 [1.07, 2.14] p = 0.018). The respective studies had different methodological strengths and weaknesses. Potential reasons for the discrepant conclusions include study power, particularly important to dissect specific cancers where differential contributions from HHT genotypes and environmental confounders might be predicted.Keywords
This publication has 7 references indexed in Scilit:
- Cancer incidence in patients with hereditary hemorrhagic telangiectasiaJournal of Cancer Research and Clinical Oncology, 2016
- Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesPLOS ONE, 2016
- JP–HHT phenotype in Danish patients with SMAD4 mutationsClinical Genetics, 2015
- Cumulative Radiation dose in Patients with Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous MalformationsCanadian Association of Radiologists Journal, 2014
- Improved Survival Outcomes in Cancer Patients with Hereditary Hemorrhagic TelangiectasiaCancer Epidemiology, Biomarkers & Prevention, 2014
- Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controlsOrphanet Journal of Rare Diseases, 2013
- Hereditary haemorrhagic telangiectasia: a population‐based study of prevalence and mortality in Danish patientsJournal of Internal Medicine, 1999